Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03507777 · ClinicalTrials.gov registry record · NA
ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 2,487
- Enrollment target
NCT03507777: Completed NA study, sponsored by Abbott Medical Devices.
NCT03507777 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,487 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03507777, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,487 participants
- Enrollment target
Study Summary
The objective of this prospective, single-blind clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy as compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and improving clinical cardiovascular outcomes in patients with high-risk clinical characteristics and/or with high-risk angiographic lesions.
Primary Outcome
Minimal Stent Area (per target lesion basis) assessed by OCT in each randomized arm, measured at an independent OCT core laboratory blinded to imaging modality assignment.
Interventions
- DEVICE Coronary PCI guided by OCT
- DEVICE Coronary PCI guided by Angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,487 participants |
| Start Date | 2018-05-17 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
What the finished NCT03507777 record still lists
NCT03507777 is an interventional study that assigns participants to a tested intervention. Its 2,487 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% higher).
The record links to 0 conditions, and to 2 interventions - of which Coronary PCI guided by OCT is the first listed.
NCT03507777 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03507777 about?
NCT03507777 is a clinical study titled "ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)". The objective of this prospective, single-blind clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy as compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and impr...
What is the current status of trial NCT03507777?
This trial is currently completed. It is a NA study. The enrollment target is 2,487 participants. The study started on 2018-05-17. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT03507777?
The interventions under investigation include: Coronary PCI guided by OCT (DEVICE), Coronary PCI guided by Angiography (DEVICE).
Who is sponsoring clinical trial NCT03507777?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03507777's enrollment target sits among peer trials
2,487 45th of 2000 higher than 1,956 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI